TAMMY GROSS: Open Payments
NPI 1801109350 · IRVINE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 14 payments from 6 companies in 2025. Trend: 2023 $181 · 2024 $255 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $133 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| ABBVIE INC. | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, Auvelity, XIFAXAN, VRAYLAR, MOUNJARO.
Industry payments across KY — which companies pay providers there.
